On March 23, 2025, LENSAR, Inc. entered into a merger agreement with Alcon Research, LLC, where LENSAR shareholders will receive $14.00 per share in cash and a contingent value right of $2.75 upon achieving certain milestones. The merger is subject to stockholder approval and regulatory conditions, with a potential termination fee of $8.5 million if certain conditions are met.